GABARAPL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.081000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.488300E-02
Normal-vs-Stage2
8.785200E-01
Normal-vs-Stage3
7.514400E-01
Normal-vs-Stage4
2.393400E-01
Stage1-vs-Stage2
7.995000E-03
Stage1-vs-Stage3
6.776300E-02
Stage1-vs-Stage4
8.148600E-01
Stage2-vs-Stage3
4.367600E-01
Stage2-vs-Stage4
6.109800E-02
Stage3-vs-Stage4
1.968010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.967000E-01
Normal-vs-AfricanAmerican
6.475000E-01
Normal-vs-Asian
8.090200E-01
Caucasian-vs-AfricanAmerican
6.449000E-01
Caucasian-vs-Asian
2.973000E-01
AfricanAmerican-vs-Asian
3.991000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.241200E-01
Normal-vs-Female
6.909200E-01
Male-vs-Female
7.405000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.974030E-01
Normal-vs-Age(41-60Yrs)
2.670200E-01
Normal-vs-Age(61-80Yrs)
8.812600E-01
Normal-vs-Age(81-100Yrs)
9.012600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.155800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.142400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.262100E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.701640E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.039800E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.707200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.105800E-01
Normal-vs-Daily Drinker
9.145000E-01
Normal-vs-Weekly Drinker
5.913400E-01
Normal-vs-Occasional Drinker
3.706000E-01
Normal-vs-Social Drinker
8.041400E-01
Non Drinker-vs-Daily Drinker
9.957200E-01
Non Drinker-vs-Weekly Drinker
2.713200E-01
Non Drinker-vs-Occasional Drinker
5.517800E-02
Non Drinker-vs-Social Drinker
7.725000E-01
Daily Drinker-vs-Weekly Drinker
2.959800E-01
Daily Drinker-vs-Occasional Drinker
5.856300E-02
Daily Drinker-vs-Social Drinker
7.827000E-01
Weekly Drinker-vs-Occasional Drinker
1.517750E-02
Weekly Drinker-vs-Social Drinker
2.248200E-01
Occasional Drinker-vs-Social Drinker
9.553800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.426190E-01
Normal-vs-Grade 2
1.427600E-04
Normal-vs-Grade 3
3.222600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.844400E-01
Grade 1-vs-Grade 3
3.820200E-01
Grade 1-vs-Grade 4
1.426190E-01
Grade 2-vs-Grade 3
9.220600E-01
Grade 2-vs-Grade 4
1.427600E-04
Grade 3-vs-Grade 4
3.222600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.423800E-01
Normal-vs-NonDiabetic
6.739800E-01
Diabetic-vs-NonDiabetic
1.602630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.525800E-01
Normal-vs-NoPancreatitis
7.259800E-01
Pancreatitis-vs-NoPancreatitis
7.343400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.645000E-01
Normal-vs-N1
9.137000E-01
N0-vs-N1
1.098210E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.347800E-01
Normal-vs-TP53-NonMutant
8.244400E-01
TP53-Mutant-vs-TP53-NonMutant
5.882400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
